Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2014
03/12/2014CN102351853B Azilsartan medoxomil compound, preparation method and medicinal composition thereof
03/12/2014CN102325754B Cyclic compound having hetero atom
03/12/2014CN102302456B Preparation method of tilmicosin phosphate microsphere specifically for use on animals
03/12/2014CN102293753B Coenzyme Q10 nanosuspension freeze-dried composition and preparation method and application thereof
03/12/2014CN102292079B Compositions and methods of treatment comprising ceftaroline
03/12/2014CN102260186B N-(4-carboxyl phenyl)retinamide ethanol compound and preparation method thereof, and medicinal composition
03/12/2014CN102256930B Polyunsaturated fatty acid and diol ester as anti-acne agent
03/12/2014CN102239168B Substituted piperidine spiro pyrrolidinone and piperidinones used as H3 modulators
03/12/2014CN102210670B Use of flavonol compound in preparation of antihypoxic medicines or foods
03/12/2014CN102210648B High-concentration furacilin micro emulsion washing fluid and preparation method and use thereof
03/12/2014CN102206214B Benzopyrone derivative and application thereof
03/12/2014CN102203099B Novel compound with spiro chiral carbon backbone, preparation method thereof, and pharmaceutical composition containing same
03/12/2014CN102198099B Toltrazuril suspension and preparation method thereof
03/12/2014CN102186978B Compositions and methods for inhibiting expression of transthyretin
03/12/2014CN102186824B Fused-ring derivative and medical application of same
03/12/2014CN102180846B Resveratrol dimer derivative and preparation and application methods thereof
03/12/2014CN102167687B Compound and application thereof in preparation of anti-tumor pharmaceutical, food or cosmetic
03/12/2014CN102151337B Compositions and methods for regulated protein expression in gut
03/12/2014CN102143761B Agent for treating myelofibrosis
03/12/2014CN102137666B Chemical compounds 251
03/12/2014CN102105150B Phosphorous derivatives as kinase inhibitors
03/12/2014CN102091079B Method and composition for transdermal drug delivery
03/12/2014CN102066396B Medicine composition as gastric antisecretory and antiulcer agents
03/12/2014CN102065854B Combination of pilocarpin and methimazol for treating charcot-marietooth disease and related disorders
03/12/2014CN102060875B Quinazoline derivative, and preparation method and application thereof
03/12/2014CN102056919B 取代的磺酰胺衍生物 Substituted sulfonamide derivative
03/12/2014CN102026987B Therapeutic agent for pain
03/12/2014CN101998958B Thieno-and furo-pyrimidine modulators of histamine H4 receptor
03/12/2014CN101983193B Prophylactic or therapeutic agent for attention deficit/hyperactivity disorder
03/12/2014CN101945661B Nutraceutical composition and methods of use
03/12/2014CN101935303B Broadspectrum substituted benzimidazole sulfonamide HIV protease inhibitors
03/12/2014CN101925602B Crystalline form of abacavir that is essentially free of solvent
03/12/2014CN101903378B Aminotriazole derivatives
03/12/2014CN101891775B 6-hydroxy-2-O-beta-D-glucopyranose base heptane, and preparation method and application thereof
03/12/2014CN101884784B Bv8 nucleic acids and polypeptides with mitogenic activity
03/12/2014CN101880381B Segmented copolymer modified by polyethylene glycol 1000 vitamin E succinic acid ester, preparation method and applications thereof
03/12/2014CN101868156B Citrulline-containing drink
03/12/2014CN101863903B 1,4-dihydrobithiophene [3', 2': 5, 6] bithiapyran [4, 3-c] pyrazol-3-carboxylic acid derivative and application thereof
03/12/2014CN101842368B Quinazolinedione derivatives, preparation thereof and therapeutic uses thereof
03/12/2014CN101821266B Modulators of cystic fibrosis transmembrane conductance regulator
03/12/2014CN101808627B Antiseptics
03/12/2014CN101801980B Tricyclic heterocyclic derivatives
03/12/2014CN101801973B 6-triazolopyridazinesulfanyl benzothiazole and benzimidazole derivatives, method for production thereof and application as medicaments and pharmaceutical compositions and use as met inhibitors
03/12/2014CN101784272B Antiviral composition comprising sulfated polysaccharide
03/12/2014CN101759560B Manufacturing method and use of trans-3-substituted phenyl acrylic acid derivative
03/12/2014CN101755049B Primary micro RNA expression cassette
03/12/2014CN101720318B Quinazolin-oxime derivatives as Hsp90 inhibitors
03/12/2014CN101717416B Derivative of alpha-amino phosphonic acid containing saccharide groups, preparation method and medical application thereof
03/12/2014CN101679350B Quinoline derivatives for treatment of inflammatory diseases
03/12/2014CN101679191B Di(hetero)arylcyclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them
03/12/2014CN101675053B Phosphoinositide 3-kinase inhibitor compounds and methods of use
03/12/2014CN101662937B Cancer treatment method
03/12/2014CN101657096B Compositions and methods for bone formation and remodeling
03/12/2014CN101642426B Baicalin adhesion type nanometer eye drops and preparation method thereof
03/12/2014CN101641332B Derivatives of aminated hydroxyquinoline class for treating cancers
03/12/2014CN101565385B Pigling intestinal tract nutrition regulation and control substance N-carbamoylglutamine and preparation method
03/12/2014CN101558055B Spiro substituted compounds as angiogenesis inhibitors
03/12/2014CN101541960B Partial fragment of REIC/Dkk-3 gene and therapeutic agent for cancer containing same
03/12/2014CN101541785B Substituted dihydropyrazolones and use thereof as HIF-prolyl-4 -hydroxylase inhibitors
03/12/2014CN101475552B Flavonol derivative and use for anti-platelet aggregation
03/12/2014CN101466390B Pharmaceutical composition with synergistic anticonvulsant effect
03/12/2014CN101456872B Thiazole[3,2-alpha] miazine derivates and use thereof
03/12/2014CN101420942B Small-molecule modulators of TRP-P8 activity
03/12/2014CN101378725B Compounds useful as agonists of A2A adenosine receptors, cosmetic compositions with A2A agonists and method for using same
03/12/2014CN101360429B Method for stimulating intestinal barrier integrity after non-natural birth
03/12/2014CN101217952B Composition for preventing occurrence of cardiovascular event
03/12/2014CN101027061B Pharmaceutical formulations and uses thereof in treatment of female sexual dysfunction
03/11/2014US8669399 Process for preparing substituted 3-(1-amino-2-methylpentane-3-yl)phenyl compounds
03/11/2014US8669381 Chromone inhibitors of S-nitrosoglutathione reductase
03/11/2014US8669380 Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives
03/11/2014US8669376 Cytotoxin compounds and methods of isolation
03/11/2014US8669370 Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
03/11/2014US8669293 Method and compositions for preventing hormone induced adverse effects
03/11/2014US8669292 Therapeutic formulation
03/11/2014US8669291 Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors
03/11/2014US8669290 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid
03/11/2014US8669289 Methods and compositions relating to hematologic malignancies
03/11/2014US8669288 Lysine salts of 4-((phenoxyalkyl)thio)-phenoxyacetic acid derivatives
03/11/2014US8669287 Emulsifying preparation
03/11/2014US8669286 SARMs and method of use thereof
03/11/2014US8669284 Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound
03/11/2014US8669283 Beta-lactones as antibacterial agents
03/11/2014US8669281 Prodrugs of fumarates and their use in treating various diseases
03/11/2014US8669280 Antiviral compounds and methods
03/11/2014US8669277 Solid forms of an azocyclic amide
03/11/2014US8669275 Deuterium-enriched donepezil
03/11/2014US8669274 Metalloenzyme inhibitor compounds
03/11/2014US8669273 Antineoplastic combinations of 4-anilino-3-cyanoquinolines and capecitabine
03/11/2014US8669272 2,5-disubstituted piperidine orexin receptor antagonists
03/11/2014US8669271 Compounds, pharmaceutical compositions and uses thereof
03/11/2014US8669270 SNS-595 and methods of using the same
03/11/2014US8669269 Imidazopyridine derivatives which inhibit the secretion of gastric acid
03/11/2014US8669268 Deuterium-enriched prasugrel
03/11/2014US8669267 Pharmaceutical, food or beverage having inhibitory activity on serotonin transporter
03/11/2014US8669266 Quinoline-carboxamide derivatives as P2Y12 antagonists
03/11/2014US8669265 Hydrated form of erlotinib free base and a process for preparation of erlotinib hydrochloride polymorph form a substantially free of polymorph form B
03/11/2014US8669264 Rutaecarpine derivatives for activating CYP1A2 in a subject
03/11/2014US8669263 Use of TAM receptor inhibitors as antimicrobials
03/11/2014US8669262 3,5-diamino-6-chloro-N-(N-(4-(4-(2-(hexyl(2,3,4,5,6-pentahydroxyhexyl)amino)ethoxy)phenyl)butyl)carbamimidoyl)pyrazine-2-carboxamide
03/11/2014US8669261 Acrylomido derivatives useful as inhibitors of the mitochondrial permeability transition
1 ... 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 ... 7860